<...they do not seem to have much money left in the till and with their current burn rate, what 3 quarters?
Dr. Z, they received $15 million in Dec. and will receive $10 million next month along with FDA approval plus similar amounts when a marketing agreement in Europe is made.
Tostrex is followed by Tostrelle, the female version of Tostrex, pending FDA approval and marketing deals later this year.
25% of the shares have been swallowed up over the last few months. CLGY has some big bang potential.